Annual Retained Earnings
-$614.65 M
-$219.71 M-55.63%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual retained earnings is -$614.65 million, with the most recent change of -$219.71 million (-55.63%) on December 31, 2023.
- During the last 3 years, RNAC annual retained earnings has fallen by -$210.02 million (-51.90%).
- RNAC annual retained earnings is now -632.77% below its all-time high of -$83.88 million, reached on December 1, 2014.
Performance
RNAC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$681.82 M
-$24.18 M-3.68%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly retained earnings is -$681.82 million, with the most recent change of -$24.18 million (-3.68%) on September 1, 2024.
- Over the past year, RNAC quarterly retained earnings has dropped by -$10.35 million (-1.54%).
- RNAC quarterly retained earnings is now -511.45% below its all-time high of -$111.51 million, reached on December 1, 2015.
Performance
RNAC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RNAC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.6% | -1.5% |
| 3 y3 years | -51.9% | -72.6% |
| 5 y5 years | -119.2% | -72.6% |
RNAC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | at low | -73.5% | at low |
| 5 y | 5-year | -83.1% | at low | -103.1% | at low |
| alltime | all time | -632.8% | at low | -511.4% | at low |
Cartesian Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$681.82 M(+3.7%) |
| Jun 2024 | - | -$657.63 M(-2.1%) |
| Mar 2024 | - | -$671.47 M(+9.2%) |
| Dec 2023 | -$614.65 M(+55.6%) | -$614.65 M(+40.7%) |
| Sep 2023 | - | -$436.99 M(+2.1%) |
| Jun 2023 | - | -$427.99 M(+2.7%) |
| Mar 2023 | - | -$416.60 M(+5.5%) |
| Dec 2022 | -$394.94 M(-8.2%) | - |
| Dec 2022 | - | -$394.94 M(-1.5%) |
| Sep 2022 | - | -$400.83 M(+2.0%) |
| Jun 2022 | - | -$392.94 M(-2.1%) |
| Mar 2022 | - | -$401.54 M(-6.7%) |
| Dec 2021 | -$430.32 M(+6.3%) | -$430.32 M(-2.8%) |
| Sep 2021 | - | -$442.56 M(+4.2%) |
| Jun 2021 | - | -$424.66 M(-1.1%) |
| Mar 2021 | - | -$429.23 M(+6.1%) |
| Dec 2020 | -$404.63 M | -$404.63 M(+4.0%) |
| Sep 2020 | - | -$389.18 M(+2.6%) |
| Jun 2020 | - | -$379.45 M(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$355.37 M(+5.8%) |
| Dec 2019 | -$335.75 M(+19.7%) | -$335.75 M(+4.6%) |
| Sep 2019 | - | -$320.87 M(+3.9%) |
| Jun 2019 | - | -$308.87 M(+5.6%) |
| Mar 2019 | - | -$292.48 M(+4.3%) |
| Dec 2018 | -$280.40 M(+29.3%) | -$280.40 M(+6.6%) |
| Sep 2018 | - | -$263.15 M(+6.5%) |
| Jun 2018 | - | -$247.15 M(+8.2%) |
| Mar 2018 | - | -$228.36 M(+5.3%) |
| Dec 2017 | -$216.90 M(+43.1%) | -$216.90 M(+9.9%) |
| Sep 2017 | - | -$197.35 M(+8.0%) |
| Jun 2017 | - | -$182.68 M(+9.6%) |
| Mar 2017 | - | -$166.71 M(+10.0%) |
| Dec 2016 | -$151.58 M(+35.9%) | -$151.58 M(+10.2%) |
| Sep 2016 | - | -$137.49 M(+6.0%) |
| Jun 2016 | - | -$129.76 M(+7.2%) |
| Mar 2016 | - | -$121.05 M(+8.6%) |
| Dec 2015 | -$111.51 M(+32.9%) | -$111.51 M |
| Dec 2014 | -$83.88 M | - |
FAQ
- What is Cartesian Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual retained earnings year-on-year change?
- What is Cartesian Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly retained earnings year-on-year change?
What is Cartesian Therapeutics annual retained earnings?
The current annual retained earnings of RNAC is -$614.65 M
What is the all time high annual retained earnings for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual retained earnings is -$83.88 M
What is Cartesian Therapeutics annual retained earnings year-on-year change?
Over the past year, RNAC annual retained earnings has changed by -$219.71 M (-55.63%)
What is Cartesian Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RNAC is -$681.82 M
What is the all time high quarterly retained earnings for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly retained earnings is -$111.51 M
What is Cartesian Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RNAC quarterly retained earnings has changed by -$10.35 M (-1.54%)